297 related articles for article (PubMed ID: 15176661)
1. Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.
Rubin RL; Teodorescu M; Beutner EH; Plunkett RW
Lupus; 2004; 13(4):249-56. PubMed ID: 15176661
[TBL] [Abstract][Full Text] [Related]
2. [Binding of complement by anti-native desoxyribonucleic acid antibodies in systemic lupus erythematosus].
Youinou P; Le Goff P; Jouquan J; Cledes J; Pennec Y; Mottier D; Abgrall JF; Tandé D; Cam P; Le Menn G
Presse Med; 1985 Apr; 14(16):875-8. PubMed ID: 3158921
[TBL] [Abstract][Full Text] [Related]
3. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
[TBL] [Abstract][Full Text] [Related]
4. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
5. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
6. Complement fixing immune complexes containing antinuclear antibodies in patients with systemic lupus erythematosus.
Budd JJ; Moore TL; Osborn TG
J Rheumatol; 1988 Feb; 15(2):247-50. PubMed ID: 3258914
[TBL] [Abstract][Full Text] [Related]
7. Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus.
Shen GQ; Shoenfeld Y; Peter JB
Clin Rev Allergy Immunol; 1998; 16(3):321-34. PubMed ID: 9773259
[No Abstract] [Full Text] [Related]
8. [Lupus erythematosus disseminatus: model of an autoimmune disease?].
Mueller-Eckhardt C
Dtsch Med Wochenschr; 1969 May; 94(19):1024-31. PubMed ID: 4181103
[No Abstract] [Full Text] [Related]
9. Immunopathologic studies of systemic lupus erythematosus (SLE). I. Tissue-bound immunoglobulins in relation to serum antinuclear immunoglobulins in systemic lupus and in chronic liver disease with LE cell factor.
Svec KH; Blair JD; Kaplan MH
J Clin Invest; 1967 Apr; 46(4):558-68. PubMed ID: 4164259
[TBL] [Abstract][Full Text] [Related]
10. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
[TBL] [Abstract][Full Text] [Related]
11. [Studies on differing complement-fixing properties of antinuclear antibodies in the nephropathy of systemic lupus erythematosus].
Tojo T; Miyachi K; Homma M
Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):621-30. PubMed ID: 4565168
[No Abstract] [Full Text] [Related]
12. Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus.
Ballou SP; Kushner I
Clin Exp Immunol; 1979 Jul; 37(1):58-67. PubMed ID: 385188
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
[TBL] [Abstract][Full Text] [Related]
14. Speckled antinuclear antibodies in keratinocytes--what does it mean?
Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of antinuclear antibody tests in children.
McGhee JL; Kickingbird LM; Jarvis JN
BMC Pediatr; 2004 Jul; 4():13. PubMed ID: 15245579
[TBL] [Abstract][Full Text] [Related]
16. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
[TBL] [Abstract][Full Text] [Related]
17. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibodies (ANA): immunologic and clinical significance.
Fernandez-Madrid F; Mattioli M
Semin Arthritis Rheum; 1976 Nov; 6(2):83-124. PubMed ID: 62398
[TBL] [Abstract][Full Text] [Related]
19. Complement C4 fixation by the anti-La(SSB) found in normal donors and in patients with systemic lupus erythematosus.
Rader MD; Yamagata H; Reichlin M; Harley JB
J Rheumatol; 1986 Feb; 13(1):79-82. PubMed ID: 3486289
[TBL] [Abstract][Full Text] [Related]
20. Lupus band test.
Provost TT
Int J Dermatol; 1981 Sep; 20(7):475-81. PubMed ID: 7026467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
